Enhanced HDL‐cholesterol‐associated anti‐oxidant PON‐1 activity in prostate cancer patients

The Kaohsiung Journal of Medical Sciences - Tập 29 - Trang 368-373 - 2013
Muzaffer Eroglu1, Necat Yilmaz2, Soner Yalcinkaya1, Nurullah Ay2, Ozgur Aydin2, Cem Sezer3
1Urology Clinic of Antalya Education and Research Hospital of Ministry of Health, Antalya, Turkey
2Central Laboratories of Antalya Education and Research Hospital of Ministry of Health, Antalya, Turkey
3Pathology Clinic of Antalya Education and Research Hospital of Ministry of Health, Antalya, Turkey

Tóm tắt

AbstractIncreases in the generation of reactive oxygen species and decreases in antioxidant enzyme activities with aging have been reported in the prostate, and are also observed in age‐related disorders such as atherosclerosis, Alzheimer's disease, and cataracts. Several studies have demonstrated that proteins are targets for reactive oxidants in cells, and that oxidized proteins accumulate during aging, oxidative stress and in some pathological conditions. However, only a limited number of studies have actually evaluated oxidative damage in relation to HDL‐cholesterol‐associated antioxidant enzyme activities or have assessed its relationship with prostate cancer. In this study, we examined the effect of HDL‐cholesterol‐associated antioxidant enzyme activities, paraoxonase1, arylesterase and new oxidative stress parameters (total oxidant status, total antioxidant status [and oxidative stress index]) in newly‐diagnosed prostate cancer patients and healthy controls. There were no significant differences in oxidative stress parameters and lipid parameters between prostate cancer patients and controls, however, paraoxonase1 enzyme activity, and non‐HDL‐cholesterol levels were higher in prostate cancer patients than controls. The results of this study were derived from a small number of subjects, but might represent an important working hypothesis for further research in a larger number of cases to clarify the role of paraoxonase1 overproduction on the prostate and its clinical relevance.

Tài liệu tham khảo

10.3322/canjclin.57.1.43 10.1038/sj.onc.1207726 Lichtenstein P., 2000, Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland, N Engl J Med, 13, 78, 10.1056/NEJM200007133430201 Parkin D.M., 1992, Cancer incidence in five continents. Comparability and quality of data, IARC Sci Publ, 120, 45 10.1159/000474185 10.2174/0929867033456341 10.1126/science.6351251 10.3109/10715769009109662 10.1038/ng0193-73 10.1038/ng1196-334 10.1038/28406 Weber W.W., 1995, Influence of heredity on human sensitivity to environmental chemicals, Environ Mol Mutagen, 25, 102, 10.1002/em.2850250614 10.1002/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.0.CO;2-B 10.1002/mnfr.201000190 10.1111/j.1365-2362.2011.02604.x Eckerson H.W., 1983, The human serum paraoxonase/arylesterase polymorphism, Am J Hum Genet, 35, 1126 Haagen L., 1992, A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4‐nitrophenyl acetate, Eur J Clin Chem Clin Biochem, 30, 391 10.1016/j.clinbiochem.2003.11.015 Harma M., 2003, Increased oxidative stress in patients with hydatidiform mole, Swiss Med Wkly, 133, 563 10.1016/j.atherosclerosis.2010.01.025 10.1158/1541-7786.MCR-10-0008 Teiber J.F., 2011, High‐performance liquid chromatography analysis of N‐acyl homoserine lactone hydrolysis by paraoxonases, Methods Mol Biol, 692, 291, 10.1007/978-1-60761-971-0_21 10.1172/JCI1649 Aksoy‐Sagirli P., 2011, Paraoxonase‐1 192/55 polymorphisms and the risk of lung cancer in a Turkish population, Anticancer Res, 31, 2225 Uyar O.A., 2011, Investigating paraoxonase‐1 gene Q192R and L55M polymorphism in patients with renal cell cancer, Genet Mol Res, 10, 133, 10.4238/vol10-1gmr927 Brophy V.H., 2001, Effects of 5' regulatory‐region polymorphisms on paraoxonase‐gene (PON1) expression, Am J Hum Genet, 68, 1428, 10.1086/320600 10.1194/jlr.M400489-JLR200 10.1007/s00726-012-1321-z 10.1038/pcan.2011.30 10.1002/pros.21285 10.2174/1874091X01206010078
Thông tin
Thông tin xuất bản

The Kaohsiung Journal of Medical Sciences

Tập 29

368-373

Thông tin tác giả